EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of NMDA Receptor in High-Pressure Neurological Syndrome and Hyperbaric Oxygen Toxicity

Alice Bliznyuk iD, Yoram Grossman

Biomolecules · 2023

DOI: 10.3390/biom13121786 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2023. Verfasst von Alice Bliznyuk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ilse Katz Institute for Nanoscale Science and Technology (IKI), Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel. Hauptthemen laut MEDLINE: High Pressure Neurological Syndrome, Hyperbaric Oxygenation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Professional divers exposed to pressures greater than 11 ATA (1.1 MPa) may suffer from high-pressure neurological syndrome (HPNS). Divers who use closed-circuit breathing apparatus and patients and medical attendants undergoing hyperbaric oxygen therapy (HBOT) face the risk of CNS hyperbaric oxygen toxicity (HBOTx) at oxygen pressure above 2 ATA (0.2 MPa). Both syndromes are characterized by reversible CNS hyperexcitability, accompanied by cognitive and motor deficits, and N-methyl-D-aspartate receptor (NMDAR) plays a crucial role in provoking them. Various NMDAR subtypes respond differently under hyperbaric conditions. The augmented currents observed only in NMDAR containing GluN2A subunit increase glutamatergic synaptic activity and cause dendritic hyperexcitability and abnormal neuronal activity. Removal of the resting Zn2+ voltage-independent inhibition exerted by GluN2A present in the NMDAR is the major candidate for the mechanism underlying the increase in receptor conductance. Therefore, this process should be the main target for future research aiming at developing neuroprotection against HPNS and HBOTx.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High Pressure Neurological SyndromeHyperbaric OxygenationHumansReceptors, N-Methyl-D-AspartateSignal TransductionOxygen

Stichwörter der Autor:innen

GluN2AHBOTxHPNSNMDARZn2+ voltage-independent inhibitionhigh pressure

Substanzen

Receptors, N-Methyl-D-AspartateOxygen

Autor:innen und Institutionen

  • Ilse Katz Institute for Nanoscale Science and Technology (IKI), Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.
  • Department of Physiology and Cell Biology, Zlotowski Center for Neuroscience, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.

ORCID-Profile: Alice Bliznyuk

Zitieren

APA

Bliznyuk, A., & Grossman, Y. (2023). Role of NMDA Receptor in High-Pressure Neurological Syndrome and Hyperbaric Oxygen Toxicity. Biomolecules. https://doi.org/10.3390/biom13121786

Vancouver

Bliznyuk A, Grossman Y. Role of NMDA Receptor in High-Pressure Neurological Syndrome and Hyperbaric Oxygen Toxicity. Biomolecules. 2023. doi:10.3390/biom13121786

BibTeX
@article{Bliznyuk2023,
  author = {Bliznyuk, Alice and Grossman, Yoram},
  title = {Role of NMDA Receptor in High-Pressure Neurological Syndrome and Hyperbaric Oxygen Toxicity},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13121786}
}
Kostenlos starten →